Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 09, 2021 / 03:30PM GMT
Release Date Price: $383.45 (+2.57%)
Jialin Jin;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. We will get started. Hello, everyone. My name is Jay Jin, and I am part of the health care technology and distribution team here at Credit Suisse. Thanks, everyone, for joining us today. We have Birgit Girshick here today, EVP of Discovery, Safety Assessment and Biologic Solutions from Charles River Laboratories for a presentation.

By way of background, Charles River Laboratories provide essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe to accelerate the research and drug development efforts.

I will now hand it over to Birgit for the presentation. But if anyone has a question from the audience, please e-mail them to me at [email protected].

With that, Birgit, over to you.

Birgit Girshick
Charles River Laboratories International, Inc. - Corporate EVP of Discovery, Safety Assessment & Biologics Solutions

Thank you very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot